i thought the trial in indo was commencing in early june? recce not in charge of timeframe thats up to them they just oversee and help set correct trial protocols i think thers are seven different medical sites i saw somewhere that s likely a cause of some of the delay in getting that coordinsted teams organised etc no excuses but i can imagine its not easy given the differences between australian and Indonesian cultures language issues medical protocols etc anyway good to see data read outs in mid trial think say sept? Maybe earlier? given the application of recce327g in australian cases of dfi and great results i cant see why phase 3 in indonesia can be any way other than a great success but we need to go though the process to satisfy stringent external independent evaluations of the data results by the relevant authorities
all takes so much time but itll be worth it for those patient enough be great to see a start to revenue flow
RCE Price at posting:
29.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)